COVID-19

HHS announced a $1.1 billion program to keep COVID-19 vaccines and treatments free for uninsured people once the public health and national emergencies end next month in the United States.

This year’s ACP Internal Medicine Meeting is taking place in person in San Diego and virtually from April 27 to April 29.

Early treatment with oral fluvoxamine plus inhaled budesonide reduced the incidence of progression to severe disease among high-risk outpatients with COVID-19, according to research published in Annals of Internal Medicine.

Determining the safety of enoxaparin and apixaban (Eliquis, Bristol Myers Squibb/Pfizer) in patients hospitalized but not intubated with confirmed COVID-19.

Mutations have allowed SARS-CoV-2 to evade previously effective treatments and preventives that have become a crucial tool for reducing severe COVID-19 and have made treating outpatients with COVID-19 more complicated.

Bivalent messenger RNA booster vaccinations were effective for preventing COVID-19 hospitalizations and deaths in older adults, according to data presented at the European Congress of Clinical Microbiology & Infectious Diseases.

The FDA on Tuesday authorized a second bivalent COVID-19 vaccine booster shot for adults aged 65 years or older and most immunocompromised patients, among other changes the agency said will simplify the U.S. vaccine schedule.

As the product of two hard-working academic physicians, I have never been without incredible examples of leaders in the field of medicine.

Adults who previously tested positive for COVID-19 have a higher risk for developing diabetes than those who did not test positive, according to findings published in JAMA Network Open.

The number of reported cases of chlamydia, gonorrhea and syphilis in the United States increased between 2020 and 2021, CDC data show.